Doctor Loses DEA Registration After Lying on Renewal Forms
Published Date: 11/12/2026
Notice
Summary
Troy R. Lehman, D.O., lost his DEA registration because he didn’t have the proper state permission and lied on his renewal forms. Since he didn’t ask for a hearing, the DEA revoked his registration by default, stopping him from handling controlled substances. This change is effective immediately and means he can no longer legally work with these drugs.
Analyzed Economic Effects
4 provisions identified: 1 benefits, 3 costs, 0 mixed.
DEA registration revoked for Troy Lehman
The Drug Enforcement Administration revoked DEA Certificate of Registration No. BL7481649 issued to Troy R. Lehman, D.O. The revocation is effective December 14, 2026, and means he may no longer legally handle or dispense controlled substances.
Pending and future Oklahoma applications denied
The Order also denies any pending applications by Troy R. Lehman to renew or modify his DEA registration and denies any other pending application by him for additional registration in Oklahoma. This denial is issued pursuant to the same Order effective December 14, 2026.
Revocation based on state-licensure loss and falsified renewals
DEA found that Mr. Lehman lacked state authority to handle controlled substances because his Oklahoma medical license was suspended on September 18, 2025, expired by its terms on June 30, 2026, and his Oklahoma Bureau of Narcotics and Dangerous Drug registration expired on October 31, 2025. The Agency also found he materially falsified Liability Question 3 on five renewal applications dated March 28, 2013; March 22, 2016; February 27, 2019; March 2, 2022; and March 31, 2025.
15-day right to dispute official notice
The Order takes official notice that the registrant is not licensed to practice medicine in the State referenced and states that he may dispute that finding by filing a properly supported motion for reconsideration of findings of fact within fifteen calendar days of the date of the Order. Any such motion and response must be filed and served by email to the other party and to the Office of the Administrator at [email protected].
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-22954, Traci B. Lujan, A.P.R.N.; Decision and Order
Traci B. Lujan, a nurse practitioner from Utah, lost her DEA registration because she no longer has permission to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her certificate. This means she can’t legally prescribe or manage certain medications anymore, effective immediately.
2026-22843, Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027
The DEA is setting limits on how much of certain controlled drugs and chemicals can be made in 2027. This affects drug makers and anyone involved in producing or handling these substances. They’re asking for public comments by December 10, 2026, before finalizing the amounts, which helps keep drug supply safe and balanced.
Previous / Next Documents
Previous: 2026-22954, Traci B. Lujan, A.P.R.N.; Decision and Order
Traci B. Lujan, a nurse practitioner from Utah, lost her DEA registration because she no longer has permission to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her certificate. This means she can’t legally prescribe or manage certain medications anymore, effective immediately.
Next: 2026-22956, Self-Regulatory Organizations; New York Stock Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Amend Rules 7.35 and 7.35A
The New York Stock Exchange is changing when it shares auction imbalance info for IPOs. Starting soon, this info will be released no earlier than 8:00 a.m. ET and no later than 10:00 a.m. ET or when the market maker gives the first update. This tweak helps traders get clearer, timely info during IPO auctions without changing any fees or costs.